Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STX vs GSK✓SelectedUSD · GSKSTX vs GSK performance historyLatest closeAs of-12.35%11/20
Stock and ETF performance explorer

STX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+91.1%
GSK return
+6.1%
Excess return
+85.0%
Maximum drawdown
-58.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-12.3%-0.1%-12.2%-12.4%
7D-13.5%-5.3%-8.2%-15.8%
30D-34.4%-3.7%-30.8%-35.2%
3M-46.2%-7.3%-39.0%-47.3%
6M-39.1%-4.2%-34.8%-39.6%
YTD+66.5%+0.9%+65.6%+65.1%
1Y+91.1%+7.3%+83.9%+88.2%
All+91.1%+6.1%+85.0%+88.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling